VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Pernod Ricard SA vs Siemens Healthineers AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Pernod Ricard SA
RI · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Pernod Ricard SA's moat claims, evidence, and risks.
View RI analysisSiemens Healthineers AG
SHL · XETRA
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Siemens Healthineers AG's moat claims, evidence, and risks.
View SHL analysisComparison highlights
- Moat score gap: Pernod Ricard SA leads (75 / 100 vs 68 / 100 for Siemens Healthineers AG).
- Segment focus: Pernod Ricard SA has 3 segments (42.3% in Asia/Rest of the World); Siemens Healthineers AG has 4 segments (54.6% in Imaging).
- Moat breadth: Pernod Ricard SA has 4 moat types across 2 domains; Siemens Healthineers AG has 8 across 3.
Primary market context
Pernod Ricard SA
Asia/Rest of the World
Premium spirits brand ownership, marketing, and distribution
Asia-Pacific, Africa, and other emerging markets
On-trade, off-trade, distributors, and duty-free operators
Brand owner and local-market route-to-market operator
42.3%
Siemens Healthineers AG
Imaging
Diagnostic medical imaging equipment and related software/services (MRI, CT, X-ray, molecular imaging, ultrasound)
Global
Hospitals, imaging centers, clinics, and integrated delivery networks
OEM + digital platform and service provider
54.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Pernod Ricard SA strengths
Siemens Healthineers AG strengths
Segment mix
Pernod Ricard SA segments
Full profile >Europe
Oligopoly
Americas
Oligopoly
Asia/Rest of the World
Oligopoly
Siemens Healthineers AG segments
Full profile >Imaging
Oligopoly
Diagnostics
Oligopoly
Varian
Oligopoly
Advanced Therapies
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.